SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-21-002212
Filing Date
2021-03-02
Accepted
2021-03-02 08:36:05
Documents
3
Period of Report
2021-02-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT tenx_8k.htm 8-K 30029
2 PRESS RELEASE tenx_ex991.htm EX-99.1 21745
3 IMAGE tenax.jpg GRAPHIC 4576
  Complete submission text file 0001654954-21-002212.txt   59752
Mailing Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560
Business Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560 919-806-4414
TENAX THERAPEUTICS, INC. (Filer) CIK: 0000034956 (see all company filings)

IRS No.: 262593535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34600 | Film No.: 21701385
SIC: 2834 Pharmaceutical Preparations